Drug Discovery Services Industry Anticipated to Expand at 13.8% CAGR During the Forecast Period

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Drug Discovery Services Market From 2025 To 2034?

The drug discovery services market has witnessed swift expansion in recent years. Its value is projected to increase from $18.27 billion in 2024 to $20.52 billion in 2025, reflecting a compound annual growth rate (CAGR) of 12.3%. Key drivers for its historical growth include heightened R&D investment, a rising global disease burden, governmental funding and backing, the proliferation of contract research organizations (CROs), a transition towards personalized medicine, and various drug repurposing approaches.

The drug discovery services market size is anticipated to undergo significant growth in the coming years. It is forecast to expand to $34.38 billion by 2029, propelled by a compound annual growth rate (CAGR) of 13.8%. This expansion during the forecast period is primarily driven by changes in regulatory frameworks, progress in drug delivery systems, a rising interest in immunotherapy, the evolving shift towards RNA-based therapeutics, and efforts to target rare diseases. Additionally, notable trends over this period include the widespread adoption of advanced technologies, the growth of biologicals and biopharmaceuticals, increased implementation of high-throughput screening, continued advancements in virtual screening, and a concentrated focus on regenerative medicine.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8324&type=smp

Which Drivers Are Impacting The Drug Discovery Services Market?

An increasing emphasis on drug discovery trials is projected to fuel the expansion of the drug discovery services market. Ensuring the safe and effective delivery of drugs heavily relies on the crucial nature of the drug development life cycle. Consequently, clinical trials are becoming increasingly important as a fundamental element of drug development. As drug development and healthcare innovation gain significance, there has been a global rise in the demand for drug discovery trials. For example, data from ClinicalTrials.gov, a dedicated platform for clinical trial registration, indicated that in May 2023, the cumulative number of clinical trials reached 452,604 in 2023, marking an increase from 365,000 registered trials documented in 2021. Hence, the heightened attention on drug discovery trials is set to stimulate the growth of the drug discovery services market.

What Are The Primary Types Of Segments Analyzed In The Drug Discovery Services Market?

The drug discovery servicesmarket covered in this report is segmented –

1) By Type: Chemistry Services; Biology Services

2) By Process: Target Selection; Target Validation; Hit-To-Lead identification; Lead Optimization; Candidate Validation

3) By Drug Type: Biologics Drug ; Small Molecule Drug

4) By End user: Pharmaceutical And Biotechnology Companies; Academic Institutes; Other End Users

Subsegments:

1) By Chemistry Services: Medicinal Chemistry; Compound Management; High-Throughput Screening; Lead Optimization

2) By Biology Services: In Vitro Studies; In Vivo Studies; Pharmacokinetics And Pharmacodynamics (PK Or PD); Biomarker Discovery

What Trends Are Expected To Drive The Drug Discovery Services Market?

Leading companies in the drug discovery services market are introducing advanced technologies like artificial intelligence (AI) and machine learning (ML) to boost the efficiency and accuracy of the drug discovery process. Artificial Intelligence (AI) and Machine Learning (ML) are interconnected fields within computer science; AI involves creating computer systems capable of performing tasks typically requiring human intelligence, while ML, a subset of AI, focuses on algorithms and statistical models that enable computers to learn from data to make predictions or decisions. For example, in February 2024, Eurofins Discovery, a France-based company offering support services across various sectors including pharmaceuticals, revealed its innovative platform, DiscoveryAI SAFIRE (Suite of ADMET Predictions for In Silico Refinement and Evaluation). This sophisticated platform employs proprietary datasets, artificial intelligence (AI), and machine learning (ML) to improve the drug discovery process. SAFIRE is designed to accelerate the identification of new pharmaceuticals by predicting the ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) properties of molecules, utilizing data from Eurofins Discovery’s extensive BioPrint database, which has been carefully developed over years of research.

Who Are The Prominent Global Companies Shaping The Drug Discovery Services Market?

Major companies operating in the drug discovery services market are Thermo Fisher Scientific Inc., Albany Molecular Research Inc., Charles River Laboratories International Inc., Laboratory Corporation of America Holdings, Domainex Ltd., GenScript Biotech Corporation, Pharmaceutical Product Development LLC, Advinus Therapeutics Pvt. Ltd., Jubilant Biosys Ltd., Evotec AG, Syngene International Ltd., Bayer AG, Merck KGaA, Ubiquigent Ltd., Eurofins Scientific SE, AppTec Laboratory Services Inc., GVK Biosciences Private Limited, Aurigene Discovery Technologies Limited, Viva Biotech Holdings, Pharmaron Beijing Co. Ltd., Selcia Limited, Concept Life Sciences Group Limited, BioDuro LLC, ChemPartner Corporation, Aptuit LLC, Sygnature Discovery Limited, Peak Proteins Ltd., SRI International, BioAscent Discovery Limited, Sai Life Sciences Limited, Promega Corporation, MedChemExpress LLC, Aragen Bioscience Inc., WuXi STA, BioNTech SE, Moderna Inc., Gilead Sciences Inc., Vertex Pharmaceuticals Incorporated, Regeneron Pharmaceuticals Inc., Amgen Inc., Bristol-Myers Squibb Company

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Drug Discovery Services Market?

North America was the largest region in the drug discovery services market in 2024. The regions covered in the drug discovery services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Drug Discovery Services Market Report:

https://www.thebusinessresearchcompany.com/customise?id=8324&type=smp

Browse Through More Reports Similar to the Global Drug Discovery Services Market 2025, By The Business Research Company

Drug Discovery Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

3D Cell Culture Technologies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/3d-cell-culture-technologies-global-market-report

Cell Based Assays Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795